These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30392000)

  • 1. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.
    Oliver A; Wong M; Sanchez C
    South Med J; 2018 Nov; 111(11):660-665. PubMed ID: 30392000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
    Lutz P; Parcina M; Bekeredjian-Ding I; Nischalke HD; Nattermann J; Sauerbruch T; Hoerauf A; Strassburg CP; Spengler U
    PLoS One; 2014; 9(4):e93909. PubMed ID: 24714550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
    Goel A; Rahim U; Nguyen LH; Stave C; Nguyen MH
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1029-1036. PubMed ID: 28994123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Hanouneh MA; Hanouneh IA; Hashash JG; Law R; Esfeh JM; Lopez R; Hazratjee N; Smith T; Zein NN
    J Clin Gastroenterol; 2012 Sep; 46(8):709-15. PubMed ID: 22878533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis.
    Kamal F; Khan MA; Khan Z; Cholankeril G; Hammad TA; Lee WM; Ahmed A; Waters B; Howden CW; Nair S; Satapathy SK
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1109-1117. PubMed ID: 28763340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis.
    Wang W; Yang J; Liu C; Song P; Wang W; Xu H; Xia X
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):905-910. PubMed ID: 31107737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-analysis.
    Menshawy A; Mattar O; Barssoum K; AboEl-Naga AM; Salim HM; Mohamed AMF; Elgebaly A; Abd-Elsalam S
    Curr Drug Targets; 2019; 20(4):380-387. PubMed ID: 30246636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rifaximine in the prevention of the spontaneous bacterial peritonitis.
    Dănulescu RM; Ciobică A; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):315-20. PubMed ID: 24340510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic prophylaxis in liver cirrhosis].
    Restellini S; Nendaz M; Morard I
    Rev Med Suisse; 2012 Feb; 8(326):276, 278-81. PubMed ID: 22364077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis.
    Facciorusso A; Papagiouvanni I; Cela M; Buccino VR; Sacco R
    Liver Int; 2019 Aug; 39(8):1448-1458. PubMed ID: 30920712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin.
    Lutz P; Parcina M; Bekeredjian-Ding I; Hoerauf A; Strassburg CP; Spengler U
    Infection; 2014 Feb; 42(1):175-7. PubMed ID: 23526308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
    Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
    Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis.
    Inadomi J; Sonnenberg A
    Gastroenterology; 1997 Oct; 113(4):1289-94. PubMed ID: 9322524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
    Song S; Yang Y; Geng C; Tang Z; Wang C; Li X
    BMC Infect Dis; 2023 Aug; 23(1):557. PubMed ID: 37641014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current problems in the prevention and treatment of infections in patients with cirrhosis].
    Bellot P; Jara Pérez López N; Martínez Moreno B; Such J
    Gastroenterol Hepatol; 2010 Dec; 33(10):729-40. PubMed ID: 20444525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H; Kumar-M P; Sharma V; Bellam BL; Mishra S; Mahendru D; Mandavdhare HS; Medhi B; Dutta U; Singh V
    Hepatol Int; 2020 May; 14(3):399-413. PubMed ID: 32266675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis.
    Glaess SS; Attridge RL; Brady RL; Attridge RT
    Ann Hepatol; 2019; 18(6):841-848. PubMed ID: 31611065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.